A polysaccharide from Inonotus obliquus ameliorates intestinal barrier dysfunction in mice with type 2 diabetes mellitus

• DOI: 10.1016/j.ijbiomac.2022.06.071
• Publication Date: 2022-06-15T01:48:13Z
• Authors: Ling Su; Chuanxin Xin; Jintao Yang; Liran Dong; Heriban Mei; Xiaojing Dai; Qi Wang
• Keywords: Inonotus; 0301 basic medicine; Mice; 03 medical and health sciences; Diabetes Mellitus, Type 2; Polysaccharides; Basidiomycota; Dietary Carbohydrates; Animals; Humans; 3. Good health

Type 2 diabetes mellitus is a global disease that endangers human health, and the need for the development of nontoxic treatment candidates is urgent. In the present work, one homogeneous polysaccharide from Inonotus obliquus (IN) was isolated, and the protective effect and mechanism of IN on type 2 diabetes mellitus were investigated from the aspects of the intestinal barrier. IN mainly consisted of 9 monosaccharides with a Mw of 373 kDa. IN attenuated body weight loss, alleviated pathological damage, and suppressed the production of proinflammatory cytokines. Additionally, IN repaired the intestinal barrier by upregulating the expression of Ki-67, ZO-1 and MUC2. Furthermore, the abundance of Firmicutes was significantly increased with IN treatment, while the levels of Bacteroidetes were significantly inhibited. In conclusion, IN protected against type 2 diabetes mellitus by ameliorating intestinal barrier dysfunction and might serve as a novel drug candidate for type 2 diabetes mellitus.